Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs
David Dahlgren, Christian Roos, Pernilla Johansson, et al.
International Journal of Pharmaceutics (2018) Vol. 547, Iss. 1-2, pp. 158-168
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches
David Dahlgren, Hans Lennernäs
Pharmaceutics (2019) Vol. 11, Iss. 8, pp. 411-411
Open Access | Times Cited: 203
Formulation strategies to improve the efficacy of intestinal permeation enhancers,
Sam Maher, David J. Brayden
Advanced Drug Delivery Reviews (2021) Vol. 177, pp. 113925-113925
Open Access | Times Cited: 64
Safety of surfactant excipients in oral drug formulations
Sam Maher, Caroline Geoghegan, David J. Brayden
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115086-115086
Open Access | Times Cited: 25
Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review
Joseph P. O’Shea, Patrick Augustijns, Martin Brandl, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 170, pp. 106098-106098
Open Access | Times Cited: 51
Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis
Hui Wang, Yi Xiao, Hai Wang, et al.
International Journal of Pharmaceutics (2019) Vol. 566, pp. 67-76
Closed Access | Times Cited: 51
Potential for pharmaceutical excipients to impact absorption: A mechanistic review for BCS Class 1 and 3 drugs
Talia Flanagan
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 141, pp. 130-138
Closed Access | Times Cited: 49
Ex vivo permeability study of poorly soluble drugs across gastrointestinal membranes: acceptor compartment media composition
Andrejs Šitovs, Valentyn Mohylyuk
Drug Discovery Today (2024), pp. 104214-104214
Open Access | Times Cited: 5
Effects of Drugs and Excipients on Hydration Status
Ana M. Puga, Sara Lopez-Oliva, Carmen Trives, et al.
Nutrients (2019) Vol. 11, Iss. 3, pp. 669-669
Open Access | Times Cited: 42
Challenges in Permeability Assessment for Oral Drug Product Development
Mirko Koziolek, Patrick Augustijns, Constantin Berger, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 11
A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats
Janis Niessen, Nathalie Arendt, Markus Sjöblom, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025), pp. 114719-114719
Closed Access
Suitability of RPMI 2650 cell models for nasal drug permeability prediction
Nadica Sibinovska, Simon Žakelj, Katja Kristan
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 145, pp. 85-95
Closed Access | Times Cited: 33
Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations
David Dahlgren, Markus Sjöblom, Hans Lennernäs
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 411-420
Closed Access | Times Cited: 32
Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics
Marilyn N. Martinez, Jonathan P. Mochel, Sibylle Neuhoff, et al.
The AAPS Journal (2021) Vol. 23, Iss. 3
Closed Access | Times Cited: 25
Intestinal epithelium penetration of liraglutide via cholic acid pre-complexation and zein/rhamnolipids nanocomposite delivery
Xiaoyan Bao, Kang Qian, Mengjiao Xu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport
David Dahlgren, Christian Roos, Anders Lundqvist, et al.
International Journal of Pharmaceutics (2018) Vol. 549, Iss. 1-2, pp. 239-248
Closed Access | Times Cited: 31
Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model
David Dahlgren, Christian Roos, Karsten Peters, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 31-37
Closed Access | Times Cited: 26
In Vitro Biopredictive Methods: A Workshop Summary Report
Xavier Pépin, Jennifer B. Dressman, Neil Parrott, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 2, pp. 567-583
Open Access | Times Cited: 24
Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats
David Dahlgren, Tobias Olander, Markus Sjöblom, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 6, pp. 1667-1675
Open Access | Times Cited: 23
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride
Melissa Metry, Yan Shu, Bertil Abrahamsson, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 4, pp. 1513-1526
Closed Access | Times Cited: 18
Time-dependent effects on small intestinal transport by absorption-modifying excipients
David Dahlgren, Christian Roos, Anders Lundqvist, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2018) Vol. 132, pp. 19-28
Closed Access | Times Cited: 23
Rat intestinal drug permeability: A status report and summary of repeated determinations
Ilse R. Dubbelboer, David Dahlgren, Erik Sjögren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 364-376
Closed Access | Times Cited: 20
The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin
David Dahlgren, Markus Sjöblom, Mikael Hedeland, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 99-99
Open Access | Times Cited: 20
Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers
Staffan Berg, Helena Edlund, William R. F. Goundry, et al.
International Journal of Pharmaceutics (2022) Vol. 628, pp. 122238-122238
Closed Access | Times Cited: 12
Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions
Christian Roos, David Dahlgren, Erik Sjögren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 387-395
Closed Access | Times Cited: 18
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat
David Dahlgren, M. J. Cano‐Cebrián, Tobias Olander, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 242-242
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top